| Line 39: |
Line 39: |
| | | | |
| | ====Other Tests==== | | ====Other Tests==== |
| − | | + | *Measurement of faecal loss alpha1-protease inhibitor |
| | | | |
| | ===Diagnostic Imaging=== | | ===Diagnostic Imaging=== |
| | + | ====Radiography==== |
| | + | *Abdominal radigraps are usually unremarkable. |
| | + | *Thoracic radiographs may show pleural effusion, metastatic neoplasia or eveidence of histoplasmosis. |
| | | | |
| | + | ====Ultrasonography==== |
| | + | *This may reveal thickening of intestines, mesenteric lymphadenopathy or abdominal effusion. |
| | | | |
| | | | |
| | ===Histopathology=== | | ===Histopathology=== |
| − | | + | *Endoscopically guided multiple biopsies are useful. However, surgical biopsy may be required for a definitive diagnosis of lymphoma and secondary lymphangiectasia. |
| | | | |
| | ==Treatment== | | ==Treatment== |
| | + | ===Plasma transfusion=== |
| | + | *This may be required to increase plasma volume perioperatively. |
| | | | |
| | + | ===Diuretics=== |
| | + | *This can be used to reduce ascites |
| | + | *Spironolactone 1-2 mg/kg PO BID may be more effective than frusemide. |
| | | | |
| | | | |